Invention Grant
- Patent Title: Compounds for the treatment of hepatitis C
-
Application No.: US13086704Application Date: 2011-04-14
-
Publication No.: US08741884B2Publication Date: 2014-06-03
- Inventor: Tao Wang , Zhiwei Yin , Zhongxing Zhang , Annapurna Pendri , Guo Li , Samuel Gerritz , Weixu Zhai , Paul Michael Scola , Li-Qiang Sun , Eric Mull
- Applicant: Tao Wang , Zhiwei Yin , Zhongxing Zhang , Annapurna Pendri , Guo Li , Samuel Gerritz , Weixu Zhai , Paul Michael Scola , Li-Qiang Sun , Eric Mull
- Applicant Address: US NJ Princeton
- Assignee: Bristol-Myers Squibb Company
- Current Assignee: Bristol-Myers Squibb Company
- Current Assignee Address: US NJ Princeton
- Agent James Epperson
- Main IPC: A61K31/33
- IPC: A61K31/33 ; C07D487/00
Abstract:
The disclosure provides compounds of formula I, including pharmaceutically acceptable salts, as well as compositions and methods of using the compounds. The compounds have activity against hepatitis C virus (HCV) and may be useful in treating those infected with HCV.
Public/Granted literature
- US20120093767A1 Compounds for the Treatment of Hepatitis C Public/Granted day:2012-04-19
Information query
